Integra LifeSciences Holdings Corp. (IART) reported first quarter adjusted earnings per share of $0.69, compared to $0.48, prior year. On average, 13 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items.
The company reported GAAP net income of $45.4 million, or $0.53 per share, compared to $9.2 million, or $0.11 per share, last year.
Reported revenues were $360.1 million, an increase of 1.6% on a reported basis and an increase of 2.9% on an organic basis compared to the prior year. Analysts expected revenue of $349.81 million, for the quarter.
For the second quarter, the company expects revenues to be in a range of $372 million to $378 million, representing reported growth of approximately 44% to 46% and organic growth of 42% to 44%. Adjusted earnings per share are expected to be in a range of $0.63 to $0.67.
The company increased the lower end of its full-year 2021 revenue guidance by $5 million to a revised range of $1.525 billion to $1.535 billion, representing reported growth of 11% to 12% and organic growth of 12% to 13%. The company now projects towards the higher end of its full-year 2021 adjusted earnings per share guidance range of $2.86 to $2.93.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.